0 Ratings
ID

13475

Description

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Keywords

Versions (5)
  1. 3/5/15 3/5/15 -
  2. 3/9/15 3/9/15 -
  3. 4/24/15 4/24/15 -
  4. 12/15/15 12/15/15 -
  5. 2/11/16 2/11/16 -
Uploaded on

February 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    End of Study AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)

    English

    End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

    1 forms  
    End of Study
    Description

    End of Study

    End of Study Date
    Description

    End of Study Date

    Data type

    date

    Alias
    UMLS CUI-1
    C2983670
    Reason for End of Study
    Description

    Reason for End of Study

    Data type

    integer

    Alias
    UMLS CUI-1
    C2348577
    Specify if Reason for End of Study = 6 or 7
    Description

    Specify if Reason for End of Study = 6 or 7

    Data type

    text

    Alias
    UMLS CUI [1]
    C1521902
    Induction therapy I administered
    Description

    Induction therapy I administered

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C3179010
    UMLS CUI [1,2]
    C0806914
    UMLS CUI [1,3]
    C0205447
    Induction therapy II administered
    Description

    Induction therapy II administered

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C3179010
    UMLS CUI [1,2]
    C0806914
    UMLS CUI [1,3]
    C0205448
    Consolidation therapy I administered
    Description

    Consolidation therapy I administered

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C3179017
    UMLS CUI [1,2]
    C0806914
    UMLS CUI [1,3]
    C0205447
    Consolidation therapy II administered
    Description

    Consolidation therapy II administered

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C3179017
    UMLS CUI [1,2]
    C0806914
    UMLS CUI [1,3]
    C0205448
    Consolidation therapy III administered
    Description

    Consolidation therapy III administered

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C3179017
    UMLS CUI [1,2]
    C0806914
    UMLS CUI [1,3]
    C0205449
    Consolidation therapy IV administered
    Description

    Consolidation therapy IV administered

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C3179017
    UMLS CUI [1,2]
    C0806914
    UMLS CUI [1,3]
    C0205450
    Maintenance therapy administered
    Description

    Maintenance therapy administered

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0481504
    UMLS CUI [1,2]
    C0806914
    Signature
    Description

    Signature

    Date
    Description

    Date

    Data type

    date

    Alias
    UMLS CUI-1
    C0011008
    Name of Investigator
    Description

    Name of Investigator

    Data type

    text

    Alias
    UMLS CUI-1
    C2826892
    Signature of investigator
    Description

    Signature of investigator

    Data type

    text

    Alias
    UMLS CUI-1
    C2346576
    Back to the top of the page

    Similar models

    End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    End of Study
    End of Study Date
    Item
    End of Study Date
    date
    C2983670 (UMLS CUI-1)
    Item
    Reason for End of Study
    integer
    C2348577 (UMLS CUI-1)
    Reason for End of Study
    Code List
    Reason for End of Study
    CL Item
    regular End of Study (0)
    C0205272 (UMLS CUI-1)
    CL Item
    no CR after Induction (Progressive Disease) (1)
    C1335499 (UMLS CUI-1)
    CL Item
    exzessive extramedullary medical toxicity (2)
    C0013221 (UMLS CUI-1)
    CL Item
    death (3)
    C0021430 (UMLS CUI-1)
    CL Item
    relapse after CR (4)
    C0035020 (UMLS CUI-1)
    CL Item
    Withdrawal of informed consent (5)
    C0021430 (UMLS CUI-1)
    C1710677 (UMLS CUI-2)
    CL Item
    Protocol deviation (6)
    C1705236 (UMLS CUI-1)
    CL Item
    other (7)
    C0205394 (UMLS CUI-1)
    Specify if Reason for End of Study = 6 or 7
    Item
    Specify if Reason for End of Study = 6 or 7
    text
    C1521902 (UMLS CUI [1])
    Induction therapy I administered
    Item
    Induction therapy I administered
    boolean
    C3179010 (UMLS CUI [1,1])
    C0806914 (UMLS CUI [1,2])
    C0205447 (UMLS CUI [1,3])
    Induction therapy II administered
    Item
    Induction therapy II administered
    boolean
    C3179010 (UMLS CUI [1,1])
    C0806914 (UMLS CUI [1,2])
    C0205448 (UMLS CUI [1,3])
    Consolidation therapy I administered
    Item
    Consolidation therapy I administered
    boolean
    C3179017 (UMLS CUI [1,1])
    C0806914 (UMLS CUI [1,2])
    C0205447 (UMLS CUI [1,3])
    Consolidation therapy II administered
    Item
    Consolidation therapy II administered
    boolean
    C3179017 (UMLS CUI [1,1])
    C0806914 (UMLS CUI [1,2])
    C0205448 (UMLS CUI [1,3])
    Consolidation therapy III administered
    Item
    Consolidation therapy III administered
    boolean
    C3179017 (UMLS CUI [1,1])
    C0806914 (UMLS CUI [1,2])
    C0205449 (UMLS CUI [1,3])
    Consolidation therapy IV administered
    Item
    Consolidation therapy IV administered
    boolean
    C3179017 (UMLS CUI [1,1])
    C0806914 (UMLS CUI [1,2])
    C0205450 (UMLS CUI [1,3])
    Maintenance therapy administered
    Item
    Maintenance therapy administered
    boolean
    C0481504 (UMLS CUI [1,1])
    C0806914 (UMLS CUI [1,2])
    Item Group
    Signature
    Date
    Item
    Date
    date
    C0011008 (UMLS CUI-1)
    Name of Investigator
    Item
    Name of Investigator
    text
    C2826892 (UMLS CUI-1)
    Signature of investigator
    Item
    Signature of investigator
    text
    C2346576 (UMLS CUI-1)
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial